Financial statements Goodwill Pharma Polska
Balance sheet data of GOODWILL PHARMA POLSKA
|
Year
|
2020
|
2022
|
2023
|
|---|---|---|---|
| Total assets | 96 593,28 | 160 144,44 | 564 971,25 |
| A. Fixed assets | 0,00 | 0,00 | 0,00 |
| B. Current assets | 96 593,28 | 160 144,44 | 564 971,25 |
| C. Share capital contributions (basic funds) | - | 0,00 | 0,00 |
| D. Own shares (stocks) | - | 0,00 | 0,00 |
| Total liabilities | 96 593,28 | 160 144,44 | 564 971,25 |
| A. Equity | 1 812,06 | -61 845,91 | -405 775,73 |
| B. Liabilities and provisions for liabilities | 94 781,22 | 221 990,35 | 970 746,98 |
| I. Long-term liabilities | 0,00 | 47 000,00 | 307 000,00 |
| II. Short-term liabilities | 94 781,22 | 174 990,35 | 663 746,98 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.